Kevin is a Vice President at Lux and leads Lux Research’s dedicated global team of expert consultants that assist executives in the Innovation 1000 make critical decisions about technologies, markets, and strategy to position existing businesses for growth and to launch new businesses. Kevin and his team help Lux’s many clients find new technologies, partners, prioritize addressable markets, correctly interpret the competitive landscape, anticipate disruptive technologies and companies, and develop sound go-to-market and business development strategies. Kevin also led the launch all of Lux’s life science advisory practices.
Kevin has more than 20 years of industry experience in the biotechnology, market intelligence and healthcare IT industries. Prior to Lux Research, he served as VP of Advisory Services at Decision Resources, a leading pharmaceutical market research and intelligence company helping the world’s top 50 pharmas optimize therapeutic pipelines using pipeline analysis, market modeling and forecasting. He also co-founded and led an award winning SaaS-based healthcare data transformation company, and prior to that spent more than 10 years in biopharmaceutical discovery research working in neurodegenerative and metabolic diseases.
Kevin received his bachelor degrees from U.C. Berkeley, his Ph.D. from Harvard, and MBA from Bentley.